Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-25-020924
Filing Date
2025-06-20
Accepted
2025-06-20 16:37:54
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 nrxp20250617_s3.htm S-3 421057
2 EXHIBIT 4.1 ex_832473.htm EX-4.1 341828
3 EXHIBIT 23.1 ex_832346.htm EX-23.1 2817
4 EXHIBIT FILING FEES ex_832347.htm EX-FILING FEES 56423
5 logolg.jpg GRAPHIC 12860
  Complete submission text file 0001437749-25-020924.txt   841087
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

EIN.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-288205 | Film No.: 251061980
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)